PROCLAIM: Randomized Phase III Trial of Pemetrexed-Cisplatin or Etoposide-Cisplatin Plus Thoracic Radiation Therapy Followed by Consolidation Chemotherapy in Locally Advanced Nonsquamous ...
In Asia, PTCL diagnosis and management are hindered by the lack of available domain experts, limitations in infrastructure support and funding, and substantial challenges in accessing novel drugs; ...
Peripheral T-cell lymphomas (PTCL) are rare cancers, which stand for about 10% of all non-Hodgkin's lymphomas (NHL) (Harris et al., 1994; The.Non-Hodgkin's.Lymphoma.Classification.Project, 1997). They ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results